AB
Apurva Bhupendra Shah
About Apurva Bhupendra Shah
Data last updated:
Apurva Bhupendra Shah has 14 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 8 companies, including Shilpveda Infracon Llp and Saascorp Llp. Formerly with 7 companies, such as Tehoco Ventures Private Limited and Strawberry Polymers Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹843 Cr; the largest is Veeda Clinical Research Limited at ₹621 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Veeda Clinical Research Limited U73100GJ2004PLC044023 | Director | 30 Mar 2026 | 2004 | ₹621 Cr (FY 2025) | Active |
 Zetts Cosmetics Private Limited U24246MH2004PTC146152 | Director | 14 Jun 2024 | 2004 | ₹209 Cr (FY 2025) | Active |
 Jiwa Foods Private Limited U15122MH2016PTC272588 | Director | 03 Feb 2016 | 2016 | ₹12.21 Cr (FY 2025) | Active |
 Gsg Pharmaceuticals Private Limited U24290MH2021PTC371034 | Director | 12 Sep 2022 | 2021 | ₹16.5 Lakh (FY 2025) | Active |
| Enzu.Life Private Limited U52390MH2020PTC345635 | Director | 09 Sep 2020 | 2020 | ₹1.6 Lakh (FY 2025) | Active |
| Zylo House Of Brands Private Limited U47722MH2025PTC453349 | Director | 30 Jul 2025 | 2025 | – | Active |
| Flint Management Consultants Llp AAV-0852 | Partner | 15 Jan 2021 | 2020 | – | Active |
| Saascorp Llp AAT-2137 | Designated Partner | 04 Aug 2020 | 2020 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Tehoco Ventures Private Limited U20234MH2024PTC422649 | Director | 31 May 2024 | 2024 | – | Amalgamated |
| Strawberry Polymers Private Limited U25190GJ2014PTC081303 | Additional Director | 21 Jan 2015 | 2014 | ₹10.70 Cr (FY 2019) | Active |
 Alfa Corpuscles Private Limited U29294DL2007PTC163078 | Director | 30 Sep 2014 | 2007 | ₹2.01 Cr (FY 2024) | Active |
| Oshiwara Land Development Private Limited U45200MH1973PTC016274 | Director | 01 Jul 2013 | 1973 | ₹3.6 Lakh (FY 2025) | Converted To Llp |
 Synersoft Technologies Private Limited U72200GJ2008PTC053922 | Additional Director | 03 Apr 2013 | 2008 | ₹10.34 Cr (FY 2025) | Active |
| Point Hospitals Private Limited U85191MH2012PTC232379 | Director | 19 Jun 2012 | 2012 | – | Active |
| Shilpveda Infracon Llp AAB-2899 | Designated Partner | 28 Dec 2012 | 2012 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Apurva Bhupendra Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apurva Bhupendra Shah
Apurva Bhupendra Shah has 14 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 8 companies, including Shilpveda Infracon Llp and Saascorp Llp. Formerly with 7 companies, such as Tehoco Ventures Private Limited and Strawberry Polymers Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹843 Cr; the largest is Veeda Clinical Research Limited at ₹621 Cr (FY 2025).
Apurva Bhupendra Shah is associated with 8 companies as Designated Partner and Partner, including Veeda Clinical Research Limited (₹621 Cr), Zetts Cosmetics Private Limited (₹209 Cr), Jiwa Foods Private Limited (₹12.21 Cr).
Apurva Bhupendra Shah has expertise in General Business, Technology.
Apurva Bhupendra Shah has 14 years in corporate governance.
By reported revenue, the largest current company of Apurva Bhupendra Shah is Veeda Clinical Research Limited, with revenue of ₹621 Cr (FY 2025).
The 5 current companies of Apurva Bhupendra Shah that report revenue have a combined latest revenue of ₹843 Cr.
Apurva Bhupendra Shah currently holds positions at 8 companies; the 5 largest by reported revenue are Veeda Clinical Research Limited (₹621 Cr), Zetts Cosmetics Private Limited (₹209 Cr), Jiwa Foods Private Limited (₹12.21 Cr), Gsg Pharmaceuticals Private Limited (₹16.5 Lakh), Enzu.Life Private Limited (₹1.6 Lakh).